Join
Live feed
·
INSIDERFilingvia Quantisnow
GW Pharmaceuticals Plc logo

SEC Form 4: B. Douglas Snyder sold $152,208 worth of Ordinary Shares (8,400 units at $18.12), decreasing direct ownership by 12% to 61,848 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GWPH (GW Pharmaceuticals Plc) and more on Quantisnow.